SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-24-005059
Filing Date
2024-03-22
Accepted
2024-03-22 16:07:14
Documents
2
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7170
2 EX-24 DOCUMENT attachment1.htm EX-24 2124
  Complete submission text file 0001209191-24-005059.txt   10985
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIRACTA THERAPEUTICS, INC. 2533 S. COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address
Burcar Melody (Reporting) CIK: 0002016467 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 24775248